Arelis Figueroa Bruno, MD | |
2121 Ridgelake Dr Fl 3, Metairie, LA 70001-2080 | |
(504) 325-2700 | |
(504) 249-5311 |
Full Name | Arelis Figueroa Bruno |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 16 Years |
Location | 2121 Ridgelake Dr Fl 3, Metairie, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457519878 | NPI | - | NPPES |
1090565 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD.205650 (Louisiana) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Crescent City Physicians Inc | 2769370543 | 139 |
News Archive
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
Canadian children don't eat enough vegetables, fruit and dairy products during school hours, causing them to fall short of several daily dietary recommendations on school days, a new UBC study has found.
Oncolytics Biotech Inc. today announced that it has been granted its 33rd U.S. Patent, # 7,608,257, entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus." The patent claims cover methods of using reovirus in combination with currently approved chemotherapeutic agents to treat patients that are refractory to those chemotherapeutic agents alone.
"Patients with serious medical conditions frequently suffer psychological, relational, and spiritual distress that is being inadequately addressed by modern health care," writes first author Douglas Miller, M.D., Indiana University School of Medicine professor of medicine, Regenstrief Institute, Inc. research scientist, and associate director of the IU Center for Aging Research.
› Verified 6 days ago
Entity Name | Crescent City Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689722340 PECOS PAC ID: 2769370543 Enrollment ID: O20040308001058 |
News Archive
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
Canadian children don't eat enough vegetables, fruit and dairy products during school hours, causing them to fall short of several daily dietary recommendations on school days, a new UBC study has found.
Oncolytics Biotech Inc. today announced that it has been granted its 33rd U.S. Patent, # 7,608,257, entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus." The patent claims cover methods of using reovirus in combination with currently approved chemotherapeutic agents to treat patients that are refractory to those chemotherapeutic agents alone.
"Patients with serious medical conditions frequently suffer psychological, relational, and spiritual distress that is being inadequately addressed by modern health care," writes first author Douglas Miller, M.D., Indiana University School of Medicine professor of medicine, Regenstrief Institute, Inc. research scientist, and associate director of the IU Center for Aging Research.
› Verified 6 days ago
Entity Name | Southern Obgyn Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174015945 PECOS PAC ID: 0446503627 Enrollment ID: O20181106000949 |
News Archive
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
Canadian children don't eat enough vegetables, fruit and dairy products during school hours, causing them to fall short of several daily dietary recommendations on school days, a new UBC study has found.
Oncolytics Biotech Inc. today announced that it has been granted its 33rd U.S. Patent, # 7,608,257, entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus." The patent claims cover methods of using reovirus in combination with currently approved chemotherapeutic agents to treat patients that are refractory to those chemotherapeutic agents alone.
"Patients with serious medical conditions frequently suffer psychological, relational, and spiritual distress that is being inadequately addressed by modern health care," writes first author Douglas Miller, M.D., Indiana University School of Medicine professor of medicine, Regenstrief Institute, Inc. research scientist, and associate director of the IU Center for Aging Research.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Arelis Figueroa Bruno, MD 3600 Prytania St Ste 35, New Orleans, LA 70115-3678 Ph: (504) 897-8681 | Arelis Figueroa Bruno, MD 2121 Ridgelake Dr Fl 3, Metairie, LA 70001-2080 Ph: (504) 325-2700 |
News Archive
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
Canadian children don't eat enough vegetables, fruit and dairy products during school hours, causing them to fall short of several daily dietary recommendations on school days, a new UBC study has found.
Oncolytics Biotech Inc. today announced that it has been granted its 33rd U.S. Patent, # 7,608,257, entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus." The patent claims cover methods of using reovirus in combination with currently approved chemotherapeutic agents to treat patients that are refractory to those chemotherapeutic agents alone.
"Patients with serious medical conditions frequently suffer psychological, relational, and spiritual distress that is being inadequately addressed by modern health care," writes first author Douglas Miller, M.D., Indiana University School of Medicine professor of medicine, Regenstrief Institute, Inc. research scientist, and associate director of the IU Center for Aging Research.
› Verified 6 days ago
Eugene J Hoffman Iii, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4224 Houma Blvd, Suite 140, Metairie, LA 70006 Phone: 504-454-7721 Fax: 504-454-5004 | |
Dr. Vernon J Carriere, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4228 Houma Blvd Ste 410, Metairie, LA 70006 Phone: 504-883-3770 Fax: 504-883-3711 | |
Bennie Peter Nobles Jr., MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4228 Houma Blvd, Ste 410, Metairie, LA 70006 Phone: 504-883-3770 Fax: 504-883-3711 | |
Margie Ann Kahn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4720 S I 10 Service Rd W, Suite 302, Metairie, LA 70001 Phone: 504-988-8070 Fax: 504-988-8071 | |
Dr. Michael E Graham, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4430 Veterans Memorial Blvd, Metairie, LA 70006 Phone: 504-842-4155 Fax: 504-457-0296 | |
Dr. Geraldine Alba St. Germain, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4228 Houma Blvd, Ste 410, Metairie, LA 70006 Phone: 504-883-3770 Fax: 504-883-3711 | |
Dr. Amy Nicole Grace, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4720 S I-10 Service Rd, Ste 502, Metairie, LA 70001 Phone: 504-885-6060 Fax: 504-887-2114 |